Insider · CIK 0001294887

Joslyn Alan

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001294887

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-18	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+400K sh	—	—	400,000
2020-05-14	OGENORAGENICS INC · Series 1 Common Stock Warrants (right to buy)E Expiration	Director, CEO and President	EExpiration	+33.3K sh	—	—	0
2020-02-05	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+400K sh	—	—	400,000
2020-02-05	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+400K sh	—	—	400,000
2019-03-25	OGENORAGENICS INCP Purchase	Director, CEO and President	PPurchase	+66.7K sh	—	—	66,667
2019-03-25	OGENORAGENICS INC · Series 1 Common Stock Warrants (right to buy)P Purchase	Director, CEO and President	PPurchase	+33.3K sh	—	—	50,000
2019-03-25	OGENORAGENICS INC · Series 2 Common Stock Warrants (right to buy)P Purchase	Director, CEO and President	PPurchase	+33.3K sh	—	—	50,000
2018-09-27	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+400K sh	—	—	400,000
2018-06-22	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+28K sh	—	—	28,000
2018-06-16	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+115K sh	—	—	436,770
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+62.5K sh	—	—	321,520
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−26.5K sh	—	—	295,020
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+26.5K sh	—	—	321,520
2017-06-22	OGENORAGENICS INC · Employee Director Option (Right to Buy)A Award	Director, CEO and President	AAward	+140K sh	—	—	140,000
2016-06-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+62.5K sh	—	—	259,020
2016-06-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+62.5K sh	—	—	259,020
2016-06-06	OGENORAGENICS INCA Award	Director, CEO and President	AAward	+30K sh	—	—	30,000
2016-06-06	OGENORAGENICS INC · Employee Director Option (Right to Buy)A Award	Director, CEO and President	AAward	+300K sh	—	—	300,000
2015-09-11	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Director	MExercise/Conversion	+13.8K sh	$3.95	+$54.3K	13,754
2015-09-11	SYNERGY PHARMACEUTICALS LLCS Sale	Director	SSale	−500 sh	$7.24	−$3,620	13,254
2015-09-11	SYNERGY PHARMACEUTICALS LLCS Sale	Director	SSale	−3,300 sh	$7.23	−$23.9K	9,954
2015-09-11	SYNERGY PHARMACEUTICALS LLCS Sale	Director	SSale	−9,954 sh	$7.22	−$71.9K	0
2015-09-11	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−13.8K sh	—	—	196,520
2015-07-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+23K sh	—	—	210,274
2014-12-06	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+43.5K sh	—	—	187,274
2013-07-12	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+21.3K sh	—	—	128,774
2012-12-11	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+2,749 sh	—	—	107,503
2012-08-07	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+13.8K sh	—	—	104,754
2012-03-20	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+7,500 sh	—	—	91,500
2011-12-06	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+50K sh	—	—	84,000
2006-06-27	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	+15K sh	$11.06	+$166K	15,260
2006-06-27	PENWEST PHARMACEUTICALS COS Sale	Sr. Vice President, R&D.	SSale	−15K sh	$21.97	−$330K	260
2006-06-27	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)M Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	−15K sh	$11.06	−$166K	260
2006-06-26	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	+10K sh	$11.06	+$111K	10,260
2006-06-26	PENWEST PHARMACEUTICALS COS Sale	Sr. Vice President, R&D.	SSale	−10K sh	$21.78	−$218K	260
2006-06-26	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)M Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	−10K sh	$11.06	−$111K	260
2006-01-05	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	+5,000 sh	$11.06	+$55.3K	5,000
2006-01-05	PENWEST PHARMACEUTICALS COS Sale	Sr. Vice President, R&D.	SSale	−5,000 sh	$20.51	−$103K	0
2006-01-05	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)M Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	−5,000 sh	$11.06	−$55.3K	0
2006-01-04	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	+2,000 sh	$11.06	+$22.1K	2,000
2006-01-04	PENWEST PHARMACEUTICALS COS Sale	Sr. Vice President, R&D.	SSale	−2,000 sh	$20.01	−$40K	0
2006-01-04	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)M Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	−2,000 sh	$11.06	−$22.1K	0
2005-12-23	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	+2,000 sh	$11.06	+$22.1K	2,000
2005-12-23	PENWEST PHARMACEUTICALS COS Sale	Sr. Vice President, R&D.	SSale	−2,000 sh	$19.81	−$39.6K	0
2005-12-23	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)M Exercise/Conversion	Sr. Vice President, R&D.	MExercise/Conversion	−2,000 sh	$11.06	−$22.1K	0
2005-02-16	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)A Award	Sr. Vice President, R&D.	AAward	+35K sh	$10.35	+$362K	35,000
2004-06-21	PENWEST PHARMACEUTICALS COStock Option (right-to-BuyA Award	Sr. Vice President, R&D.	AAward	+100K sh	$11.06	+$1.11M	100,000
2004-06-21	PENWEST PHARMACEUTICALS COStock Option (right-to-BuyA Award	Sr. Vice President, R&D.	AAward	+100K sh	$11.06	+$1.11M	100,000

Recent filings

Accepted (ET)
Feb 194
Joslyn Alan0001493152-21-004421
SEC(opens sec.gov)
May 154
Joslyn Alan0001493152-20-009138
SEC(opens sec.gov)
Feb 74
Joslyn Alan0001493152-20-001774
SEC(opens sec.gov)
Mar 274
Joslyn Alan0000899243-19-009015
SEC(opens sec.gov)
Oct 14
Joslyn Alan0000899243-18-025657
SEC(opens sec.gov)
Jun 264
Joslyn Alan0000899243-18-018140
SEC(opens sec.gov)
Jun 194
Joslyn Alan0001104659-18-041062
SEC(opens sec.gov)
Jun 304
SYNERGY PHARMACEUTICALS, INC.0001104659-17-043011
SEC(opens sec.gov)
Jun 264
ORAGENICS INC0000899243-17-017197
SEC(opens sec.gov)
Jun 294/A
SYNERGY PHARMACEUTICALS, INC.0001104659-16-130130
SEC(opens sec.gov)
Jun 274
SYNERGY PHARMACEUTICALS, INC.0001104659-16-129537
SEC(opens sec.gov)
Jun 84
ORAGENICS INC0000899243-16-022125
SEC(opens sec.gov)
Sep 144
SYNERGY PHARMACEUTICALS, INC.0001104659-15-064977
SEC(opens sec.gov)

Companies

Address

C/O SYNERGY PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609

NEW YORK, NY, 10170